Zosyn 3.375 GM/50 ML galaxy 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHGT8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,622
Award facts
- Contract value 100% obligated
- $1,622.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,622.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML. The delivery order was issued on November 28, 2025, with an ultimate completion date of December 19, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge, Illinois location and will deliver this pharmaceutical product to support federal medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial capability across a diverse pharmaceutical portfolio encompassing branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, positioning the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHGT8?
SPE2DR26FHGT8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FHGT8 worth?
The government has obligated $1,622 on SPE2DR26FHGT8.
Is contract SPE2DR26FHGT8 an order under another contract?
Yes. SPE2DR26FHGT8 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGT8 competed?
The extent of competition for SPE2DR26FHGT8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award